Efficacy of combination immunotherapy of IgM MAb B6.1 and amphotericin B against disseminated candidiasis

International Immunopharmacology

Volumn 10, Issue 12, 2010, Pages 1526-1531

  Han, Yongmoon ^a  

^a Dongduk Women's University   (South Korea)

Author keywords

Amphotericn B; Augmentation; Candida albicans; Combination immunotherapy; Disseminated candidiasis; IgM MAb B6.1

Indexed keywords

AMPHOTERICIN B; IMMUNOGLOBULIN M ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANDIDA ALBICANS; COLONY FORMING UNIT; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; IMMUNOTHERAPY; INVASIVE CANDIDIASIS; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME; THERAPY EFFECT; YEAST CELL;

AMPHOTERICIN B; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS, INVASIVE; DISEASE MODELS, ANIMAL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; IMMUNOGLOBULIN M; MICE; MICE, INBRED BALB C; TRISACCHARIDES;

EID: 78649986381     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.08.027     Document Type: Article

References (31)

1. D.R. Schaberg, D.H. Culver, and R.P. Gayner Major trends in the microbial etiological nosocomial infection Am J Med 16 1991 72S 75S
2. G.P. Body The emergence of fungi as major hospital pathogens J Hosp Infect 11 Suppl A 1988 411 426
3. J.E. Edwards Invasive Candida infections: evolution of a fungal pathogen N Engl J Med 324 1991 1060 1072
4. S.P. Fisher-Hoch, and L. Hutwagner Opportunistic candidiasis: an epidemic of the 1980s Clin Infect Dis 21 1995 897 904
5. J.E. Edwards, G.P. Bodey, R.A. Boeden, T. Buchner, B.E. DePauw, and SG Filler International conference for the development of a consensus on the management and prevention of severe candidal infections Clin Infect Dis 25 1997 43 59
6. V.J. Anttila, P. Ruutus, S. Bondestam, S.E. Jansson, S. Nordling, and M Farkkila Hepatosplenic yeast infection in patient with acute leukemia: a dangerous problem Clin Infect Dis 18 1994 979 981
7. F.J. Fleury Adult vaginitis Clin Microbiol Rev 9 1981 345 348
8. B.J. Horowitz Mycotic vulvovaginitis: a broad overview Am J Obstet Gynecol 165 1991 1188 1192
9. H.A. Gallis, R.H. Drew, and W.W. Pickard Amphotericin B: 30 years of clinical experience Rev Infect Dis 12 1990 308 329
10. S.C. Hartsel, and J. Bolard Amphotericin B: new life for an olddrug Trends Pharmacol Sci 12 1996 445 449
11. V. Fonos, and L. Cataldi Amphotericin B-induced nephrotoxicity: a review J Chemother 12 2000 463 470
12. J. Mayer, M. Doubek, J. Doubek, D. Horky, P. Scheer, and M. Stepanek Reduced nephrotoxicity of conventionalamphotericin B therapy after minimal nephroprotective measures: animal experiments and clinical study J Infect Dis 186 2002 379 388
13. S. Matsuoka, and M. Murata Cholesterol markedly reduces ionpermeability induced by memebrane-bound amphotericin B Biochim Biophys Acta 1564 2002 429 434
14. A.M. Sugar, C.A. Hitchcock, P.F. Troke, and M. Picard Combinationtherapy of murine invasive candidiasis with fluconazole andamphotericin B Antimicrob Agents Chemother 39 1995 598 601
15. J.A. Vazquez, M.T. Argonoza, J.K. Vaishampayan, and R.A. Akins In vitro interaction between amphotericin B and azoles in Candida albicans Antimicrob Agents Chemother 40 1996 2511 2516
16. R.E. Lewis, B.C. Lund, M.E. Klepser, E.J. Ernst, and M.A. Pfaller Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicansby using a dynamic in vitro mycotic infection model Antimicrob Agents Chemother 42 1998 1382 1386
17. D. Sanglard Clinical relevance of mechanism of antifungal drug resistance in yeasts Enferm Infecc Microbiol Clin 20 2002 462 469
18. M. Masia Canuto, and F. Gutierrez Rodero Antifungal drug resistance to azoles and polyenes Lancet Infect Dis 2 2002 550 563
19. C. MacNeill, J. Weisz, and J.C. Carey Clinical resistance of recurrent Candida albicas vulvovaginitis to fluconazole in the presence and absence of in vitro resistance J Reprod Med 48 2003 63 68
20. Y. Han, T. Kanbe, R. Cherniak, and J.E. Cutler Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies Infect Immun 65 1997 4100 4107
21. Y. Han, R.P. Morrison, and J.E. Cutler A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection Infect Immun 66 1998 5771 5776
22. Y. Han, and J.E. Cutler Antibody response that protects against disseminated candidasis Infect Immun 63 1995 2714 2719
23. Y. Han, MH Riesselman, and J.E. Cutler Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody Infect Immun 68 2000 1649 1654
24. T.C. Caesar-TonThat, and J.E. Cutler A monoclonal antibody to Candida albicans enhances mouse neutrophil candidacidal activity Infect Immun 65 1997 5354 5357
25. Y. Han, T.R. Kozel, M.X. Zhang, R.S. MacGill, M.C. Carroll, and J.E. Cutler Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis J Immunol 67 2001 1550 1557
26. Y. Han, and J.H. Lee Berberine synergy with amphotericin B against disseminated candidiasis in mice Biol Pharm Bull 28 2005 541 544
27. Y. Han Synergic anticandidal effect of epigallocatechin-O-gallate combined with amphotericin B in a murine model of disseminated candidiasis and its anticandidal mechanism Biol Pharm Bull 30 2007 1693 1696
28. Y. Han, and J.E. Cutler Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals J Infect Dis 175 1997 1169 1175
29. S.H. Pincus, R.L. Cole, E. Kamanga-Sollo, and S.H. Fischer Interaction of group B steptococcal opacity variants with the host defense system Infect Immun 61 1993 3761 3768
30. T.G. Sieck, M.A. Moors, H.R. Buckley, and K.J. Blank Protection against murine disseminated candidiasis mediated by a Candida albicans-specific T-cell line Infect Immun 61 1993 3540 3543
31. T. Kanbe, Y. Han, B. Redgrave, M.H. Riesselman, and J.E. Cutler Evidence that mannans of Candida albicans are responsible for adherence of yeast forms to spleen and lymph node tissue Infect Immun 61 1993 2578 2584